XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 131,507 $ 72,691 $ 226,094 $ 130,771
General and administrative 21,474 14,456 41,359 27,567
Total operating expenses 152,981 87,147 267,453 158,338
Loss from operations (152,981) (87,147) (267,453) (158,338)
Other income, net:        
Interest income 23,813 16,451 45,479 26,844
Grant income 394 2,464 520 3,119
Realized gains on marketable securities 27 0 49 0
Foreign currency transaction gains (losses) 44 (107) (2,318) (426)
Total other income, net 24,278 18,808 43,730 29,537
Net loss $ (128,703) $ (68,339) $ (223,723) $ (128,801)
Net loss per share, basic (in dollars per share) $ (1.10) $ (0.70) $ (1.95) $ (1.40)
Net loss per share, diluted (in dollars per share) $ (1.10) $ (0.70) $ (1.95) $ (1.40)
Weighted-average shares outstanding, basic (in shares) 117,256,561 98,057,870 114,473,758 92,165,076
Weighted-average shares outstanding, diluted (in shares) 117,256,561 98,057,870 114,473,758 92,165,076